On August 8, 2026, European hematology groups highlighted the critical role of continuous immunomodulatory therapy in managing plasma cell disorders. Sourcing specialized capsules like Lenalid (Lenalidomide) 10mg Capsules remains a vital need for patients with Multiple Myeloma undergoing maintenance therapy in Spain.

At Onco Medicine, we specialize in delivering authentic, batch-verified hematological products directly to pharmacies and clinics in Spain under EU and Spanish medicines agency (AEMPS) rules.

Immunomodulation in Multiple Myeloma

Lenalidomide is a powerful immunomodulatory drug (IMiD) that works through multiple pathways to suppress myeloma cells:

• Tumor Starvation: Inhibits angiogenesis, cutting off blood supply and nutrients to myeloma cells in the bone marrow.
• Immune Activation: Stimulates T-cells and natural killer (NK) cells to actively destroy remaining malignant plasma cells.
• Maintenance Dosing: The 10mg strength is frequently used for low-dose continuous maintenance therapy post-transplant, helping to prolong progression-free survival.

EMA Pregnancy Prevention and Import Rules

Due to the structural similarity to thalidomide, Lenalidomide can cause severe birth defects. Sourcing into Spain requires strict adherence to safety programs:

• Pregnancy Prevention Plan (PPP): Female patients of childbearing potential must undergo regular medically supervised pregnancy tests and use dual contraception methods.
• AEMPS Compliance: Sourcing must be accompanied by a valid hematologist prescription written in Spanish or English and a signed patient safety declaration.
• Customs Declarations: Every shipment includes a Certificate of Analysis (COA) and compliant customs paperwork to ensure smooth, immediate clearance at Spanish border controls.

Onco Medicine handles the complex logistics to ensure safe, secure delivery of authentic Lenalid capsules directly to your clinical address.